secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001213900-25-121932
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics raises ~$2.2M in registered direct offering and private placement of shares and warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$2.2M from sale of 207,374 shares at $10.85 per share and warrants to purchase 414,748 shares.
- Warrants immediately exercisable at $10.60/share, expire 2 years after effective date of resale registration statement.
- Officers and directors subject to 10-day lock-up; company restricted from equity issuance for 10 days and variable rate transactions for one year.
- Placement agent H.C. Wainwright receives 7% cash fee and 13,479 placement agent warrants at $13.5625/share.
- Closing expected on or about December 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025121932/0001213900-25-121932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025121932/ea0269824-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-121932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer